: NEWS INDEX
The Danish government announces Entrepreneur Award
Copenhagen Business School establishes Research Center on Biotech Business
: MVA NEWS
Innovation in Medicon Valley
Debate contribution written by Stina Gestrelius, Deputy CEO, Medicon Valley Academy, published in Kemivärlden Biotech, April 2004.
More information... (in Swedish) www.mva.org/composite-598.htm
MVA Business Academy
4 May 2004 / Øresundshuset / Copenhagen
Venture capital - aspects of contracts and other selected topics relating to venture capital financing. Lecturer is Jan Presfeldt, Supreme Court Attorney, Nielsen & Nørager Law Firm and lecturer in company law, University of Copenhagen.
More information...(in English) www.mva.org/businessacademy
Danish Association for Cancer Research's Annual Meeting 2004
6 May 2004 / Vilvorde Kursuscenter / Copenhagen
Medicon Valley Academy and the Danish Association for Cancer Research invite to the annual meeting for cancer scientists in Denmark and Southern Sweden.
More information...(in Danish) www.mva.org/composite-988.htm
HR Network meeting: Wages, pensions and insurances
25 May 2004 / Øresundshuset / Copenhagen
Medicon Valley Academy invites to the third HR network meeting - Wages, pensions and insurances - this is how it works in Denmark and Sweden.
More information...(in Swedish) www.mva.org/composite-956.htm
MVA press release: 11 new biotech companies in Medicon Valley
More information...(in Danish and Swedish) www.mva.org/composite-996.htm
: MEDICON VALLEY NEWS
Funding for small biotech companies
Swedish VINNOVA (the Swedish Agency for Innovation Systems) announces funding for new business concepts/ideas in small biotech companies - application deadline: 13 May 2004
More information... (in Swedish) www.mva.org/composite-1006.htm
Stricent and Sigma InfoTech sign agreement
Stricent AB, a Swedish biotech company, is a new partner of Sigma InfoTech AB concerning sales of advantum®, a product that is expected to play a key and central role in the development of Abiocess, a Stricent product.
More information... (in Swedish) www.mva.org/composite-1007.htm
The Danish government announces Entrepreneur Prize
In September 2004, the Danish government will award their Entrepreneur prize 2004. Deadline for participation: 26 May 2004
More information... (in Danish) www.mva.org/composite-1009.htm
Copenhagen Business School establishes Research Center on Biotech Business
Recently, Copenhagen Business School (CBS) opened a new centre dedicated to research on Biotech Business. CBS wishes to focus research on the management and economic issues associated with biotechnology and with research-driven business in general.
More information... (in English) www.mva.org/composite-999.htm
U.S. Genomics licenses Locked Nucleic Acid chemistries from Exiqon
The Medicon Valley based biotech company Exiqon and U.S. Genomics have entered into a worldwide license agreement to incorporate Exiqon’s Locked Nucleic Acid chemistries into reagent kits for a U.S. Genomics platform.
More information... (in English) www.mva.org/composite-1004.htm
Lund University and Karolinska Institutet enter unique and ground-breaking collaboration
The two succesful Swedish universities Lund University and Karolinska Institutet have entered a collaboration to develop and commercialise research results within the life science sector.
More information... (in Swedish) www.mva.org/composite-998.htm
New Danish biotech spin-out from Hvidovre Hospital
LNA Bacterial Detection is a new Danish biotech company based on research at Hvidovre Hospital.
More information... (in Danish) www.mva.org/composite-972.htm
: EVENTS
Statistical issues in Drug Development
6 May 2004 / Malmö / Sweden
One-day conference organised by the Swedish Association of Medical Statistics and The Danish Society for Biopharmaceutical Statistics.
More information... (in English) www.mva.org/composite-1008.htm
Seven Challenges for Sustainability - Combating HIV/AIDS, Malaria and TB
12 May 2004 / Lund University / Sweden
Why are 250 000 babies born with HIV each year, when it’s preventable? For who is cure more profitable than prevention? This one-day seminar addresses efforts to bring new innovations from the test phase to benefiting people that need measures most.
More information... (in English) www.mva.org/composite-1005.htm
Emerging Technologies in Biomedical Research
24-25 May 2004 / Lund University / Sweden
The progress in biomedical research is to a large extent technology-driven. To illustrate research possibilities available now and within the near future made possible through new state-of-the-art techniques, the Biomedical Center, Lund University invites leading scientist to a top-level symposium/workshop that will focus on emerging technologies.
More information...(in English) www.mva.org/composite-940.htm
XVIIIth International Symposium on Medicinal Chemistry
15-19 August 2004 / Copenhagen, Denmark & Malmö, Sweden
The International Symposium on Medicinal Chemistry 2004 will illustrate the integration of the complementary industrial and academic drug design approaches.
More information (in English) www.mva.org/composite-918.htm
BioTech Forum + ScanLab 2004
5-7 October 2004 / Bella Center / Copenhagen
Stockholm International Fairs, Life Science Technologies and MVA invite to Scandinavia's most important biotechnology and biomedicine event - a trade fair focusing on R&D and laboratory equipment; a science conference with national and international key speakers presenting their latest research within the regional key competences and interdisciplinary areas; and a business summit for bringing together executives and decision makers from the life science industry to meet, evaluate and explore opportunities to collaborate and create business.
More information...(in English) www.mva.org/composite-938.htm
: NEW MVA MEMBERS - See complete membership list
SixSteps AB - www.sixsteps.se - a Swedish company which wants to become a leading supplier of IT solutions for integrating the complex information structures that is the output from R&D projects by offering future proof digital archiving of data and information in a generic format that makes re-use and re-integration into any new context easy to do.
MediTeam Consulting ApS - www.mediteam-consulting.com - a Danish company offering consulting services to emerging and established companies operating within the areas of Pharmaceuticals, Biotechnology, Diagnostics and Medical Devices.
Walstijn Intellectual Property ApS - www.wippatent.dk - a dedicated patent attorney firm in Copenhagen specializing in representation before the European Patent Office. Walstijn Intellectual Property can assist you in protecting your invention and advise you on many other aspects of patent related issues.
Stricent AB - www.stricent.com - a Swedish company on the border between biotech and IT providing software and services for biotech and pharmaceutical development. The company has two products: a system for biomedical development and a system for electronic data capture used in clinical trials.
ViroGates ApS - www.virogates.com - a Danish biotech company focused on HIV research and disease prognostics. Through innovative research and strategic partnering, ViroGates aims to develop and distribute prognostic and pharmacological products for infectious disease management with a simple goal in mind: to improve the lives of HIV and other seriously infected individuals on all continents.
Unit One - www.unit-one.dk - a Danish company helping customers and business partners to accelerate their R&D activities. Unit One's solutions are based on Vision Tecknology, and they work together with their customers to solve everything from routine jobs to even the most complex problems having to do with vision.
Kelly Scientific Resources - www.kellyscientific.com - the scientific business unit of Kelly Services, a global staffing industry leader. Kelly Scientific Resources provides scientific staffing services on a temporary, project and full-time basis to a broad spectrum of industries including amongst others: chemical, medical/clinical, pharmaceutical and biomedical.
Essentys AB - www.gramineer.com - a Swedish biopharmaceutical company specialising in the discovery, selection and clinical development of biomolecules with the capacity to improve health and quality of life. The first drug candidate, ES 1, is under clinical development for the treatment and prevention of osteoporosis.